Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation

Nature Medicine

Volumn 20, Issue 10, 2014, Pages 1147-1156

  Mayo, Lior ^a   Trauger, Sunia A ^b   Blain, Manon ^c   Nadeau, Meghan ^a   Patel, Bonny ^a   Alvarez, Jorge I ^d   Mascanfroni, Ivan D ^a   Yeste, Ada ^a   Kivisäkk, Pia ^a   Kallas, Keith ^a   Ellezam, Benjamin ^e   Bakshi, Rohit ^a   Prat, Alexandre ^d   Antel, Jack P ^c   Weiner, Howard L ^a   Quintana, Francisco J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B4GALT6 PROTEIN, MOUSE; CCL2 PROTEIN, MOUSE; CDW17 ANTIGEN; GALACTOSYLTRANSFERASE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; GLYCOLIPID; LACTOSYLCERAMIDE; LEUKOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE PROTEIN;

ANIMAL; ASTROCYTE; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENE SILENCING; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NONOBESE DIABETIC MOUSE; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIGENS, CD; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CHEMOKINE CCL2; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GALACTOSYLTRANSFERASES; GENE KNOCKDOWN TECHNIQUES; GLYCOLIPIDS; HUMANS; IMMUNITY, INNATE; LACTOSYLCERAMIDES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; UP-REGULATION;

EID: 84925060157     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3681     Document Type: Article

References (51)

1. Clarke, L.E., Barres, B.A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 14, 311-321 (2013).
2. Rouach, N., Koulakoff, A., Abudara, V., Willecke, K., Giaume, C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322, 1551-1555 (2008).
3. Seifert, G., Schilling, K., Steinhauser, C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 7, 194-206 (2006).
4. Tsai, H.H. et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 337, 358-362 (2012).
5. Bush, T.G. et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23, 297-308 (1999).
6. Myer, D.J., Gurkoff, G.G., Lee, S.M., Hovda, D.A., Sofroniew, M.V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129, 2761-2772 (2006).
7. Toft-Hansen, H., Fuchtbauer, L., Owens, T. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59, 166-176 (2011).
8. Voskuhl, R.R. et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29, 11511-11522 (2009).
9. Mayo, L., Quintana, F.J., Weiner, H.L. The innate immune system in demyelinating disease. Immunol. Rev. 248, 170-187 (2012).
10. Nylander, A., Hafler, D.A. Multiple sclerosis. J. Clin. Invest. 122, 1180-1188 (2012).
11. Weiner, H.L. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann. Neurol. 65, 239-248 (2009).
12. Joseph, J., Bittner, S., Kaiser, F.M., Wiendl, H., Kissler, S. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. J. Immunol. 188, 216-221 (2012).
13. Basso, A.S. et al. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest. 118, 1532-1543 (2008).
14. Farez, M.F. et al. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat. Immunol. 10, 958-964 (2009).
15. Cao, W. et al. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 35, 273-284 (2011).
16. Pluchino, S. et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688-694 (2003).
17. Chatterjee, S., Alsaeedi, N. Lactosylceramide synthase as a therapeutic target to mitigate multiple human diseases in animal models. Adv. Exp. Med. Biol. 749, 153-169 (2012).
18. Pannu, R., Won, J.S., Khan, M., Singh, A.K., Singh, I. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J. Neurosci. 24, 5942-5954 (2004).
19. Ajami, B., Bennett, J.L., Krieger, C., McNagny, K.M., Rossi, F.M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142-1149 (2011).
20. Izikson, L., Klein, R.S., Charo, I.F., Weiner, H.L., Luster, A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075-1080 (2000).
21. Mildner, A. et al. CCR26Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132, 2487-2500 (2009).
22. Watkins, T.A., Emery, B., Mulinyawe, S., Barres, B.A. Distinct stages of myelination regulated by ?-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60, 555-569 (2008).
23. Nishie, T. ?4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 20, 1311-1322 (2010).
24. Tokuda, N. et al. ?4GalT6 is involved in the synthesis of lactosylceramide with less intensity than ?4GalT5. Glycobiology 23, 1175-1183 (2013).
25. Yan, Y. et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol. Ther. 20, 1338-1348 (2012).
26. Lee, J.K. et al. Lactosylceramide mediates the expression of adhesion molecules in TNF-? and IFN?-stimulated primary cultured astrocytes. Korean J. Physiol. Pharmacol. 15, 251-258 (2011).
27. Huang, D.R., Wang, J., Kivisakk, P., Rollins, B.J., Ransohoff, R.M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193, 713-726 (2001).
28. Heppner, F.L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (2005).
29. David, S., Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399 (2011).
30. Lawrence, T., Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761 (2011).
31. Murray, P.J., Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
32. Ponomarev, E.D. et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39-48 (2007).
33. Gong, N., Wei, H., Chowdhury, S.H., Chatterjee, S. Lactosylceramide recruits PKC?/? and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. Proc. Natl. Acad. Sci. USA 101, 6490-6495 (2004).
34. Nakamura, H. et al. Lactosylceramide interacts with and activates cytosolic phospholipase A2?. J. Biol. Chem. 288, 23264-23272 (2013).
35. Ho, P.P. et al. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci. Transl. Med. 4, 137-173 (2012).
36. Jahng, A. et al. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957 (2004).
37. Kanter, J.L. et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 12, 138-143 (2006).
38. Quintana, F.J. et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. USA 105, 18889-18894 (2008).
39. Quintana, F.J., Yeste, A., Weiner, H.L., Covacu, R. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J. Neuroimmunol. 248, 53-57 (2012).
40. Schwab, J.M., Chiang, N., Arita, M., Serhan, C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007).
41. Nolte, C. et al. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33, 72-86 (2001).
42. Cardona, A.E., Huang, D., Sasse, M.E., Ransohoff, R.M. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 1, 1947-1951 (2006).
43. Cahoy, J.D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278 (2008).
44. Prinz, M., Priller, J., Sisodia, S.S., Ransohoff, R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227-1235 (2011).
45. Zamanian, J.L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391-6410 (2012).
46. Ulitsky, I. et al. Expander: from expression microarrays to networks and functions. Nat. Protoc. 5, 303-322 (2010).
47. Saura, J., Tusell, J.M., Serratosa, J. High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189 (2003).
48. Kunis, G. et al. IFN-?-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair. Brain 136, 3427-3440 (2013).
49. Menheniott, T.R., Charalambous, M., Ward, A. Derivation of primary choroid plexus epithelial cells from the mouse. Methods Mol. Biol. 633, 207-220 (2010).
50. Jack, C.S. et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175, 4320-4330 (2005).
51. Alvarez, J.I. et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731 (2011).